Top 10 Companies in the Lactulose Concentrate Syrup Market (2026): Market Leaders Powering Global Therapeutics

MARKET INSIGHTS

Global lactulose concentrate syrup market size was valued at USD 165.8 million in 2025 and is projected to reach USD 235.4 million by 2034, exhibiting a CAGR of 4.3% during the forecast period.

Lactulose concentrate syrup is a synthetic sugar solution primarily used in pharmaceutical applications for treating chronic constipation and hepatic encephalopathy. As an osmotic laxative, it works by drawing water into the colon to soften stools while also reducing blood ammonia levels in liver disease patients, making it a critical therapeutic option in gastroenterology and hepatology.

The market growth is being driven by increasing prevalence of digestive disorders and liver diseases, particularly among aging populations. North America currently holds the largest market share due to high healthcare awareness and established treatment protocols, while Asia-Pacific is emerging as the fastest-growing regional market because of expanding healthcare infrastructure and rising diagnosis rates. Pharmaceutical-grade purity variants (particularly 70% concentration) dominate product demand, though food industry applications as a prebiotic ingredient are gaining traction.

Lactulose Concentrate Syrup Market – View in Detailed Research Report

---

Top 10 Companies in the Lactulose Concentrate Syrup Market (2026)

1️⃣ 1. Abbott Laboratories

Headquarters: Abbott Park, Illinois, USA
Key Offering: Branded lactulose formulations for constipation and hepatic encephalopathy

Abbott Laboratories has leveraged its extensive pharmacy and clinical network to position lactulose as a first‑line therapy for chronic constipation and hepatic encephalopathy. The company’s focus on patient‑centric care, coupled with robust clinical data, has reinforced prescriber confidence and sustained high prescription volumes across North America and Europe.

Sustainability & Growth Initiatives:

• Investment in high‑purity 70% formulations to meet stringent regulatory standards.
• Expansion of digital health partnerships to support remote monitoring of liver disease patients.
• Commitment to reducing carbon footprint in manufacturing through renewable energy adoption.

2️⃣ 2. Fresenius Kabi AG

Headquarters: Bad Homburg, Germany
Key Offering: Clinical nutrition and lactulose therapy for inpatient and outpatient settings

Fresenius Kabi’s integrated clinical nutrition platform enables seamless delivery of lactulose to hospitals and specialty care centers, ensuring consistent supply and adherence. The company’s global supply chain resilience has positioned it as a preferred partner for national health systems.

Sustainability & Growth Initiatives:

• Scaling up of GMP‑certified production facilities in emerging markets.
• Partnerships with pharmaceutical distributors to enhance market penetration.
• Implementation of circular economy practices in packaging materials.

3️⃣ 3. Morinaga Milk Industry Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: Bulk lactulose concentrate for pharmaceutical and food‑grade applications

Morinaga’s proprietary enzymatic conversion technology from whey‑derived lactose allows high‑yield, high‑purity lactulose production. The company supplies both pharmaceutical and food‑grade customers worldwide, capitalizing on the growing demand for prebiotic ingredients.

Sustainability & Growth Initiatives:

• Investment in renewable dairy processing to lower CO₂ emissions.
• Expansion of production capacity in Asia‑Pacific to meet regional demand.
• Development of low‑volume, high‑concentration formulations for pediatric use.

4️⃣ 4. Biofac A/S

Headquarters: Copenhagen, Denmark
Key Offering: Bulk lactulose concentrate for European pharmaceutical markets

Biofac’s long‑standing expertise in specialty carbohydrate manufacturing has enabled it to deliver high‑purity lactulose to a broad portfolio of pharmaceutical clients across Europe and beyond.

Sustainability & Growth Initiatives:

• Adoption of energy‑efficient production lines.
• Collaboration with academic institutions to explore prebiotic applications.
• Strategic alliances with contract manufacturers to enhance scalability.

5️⃣ 5. Solactis

Headquarters: Paris, France
Key Offering: Specialty carbohydrate manufacturing for lactulose and related products

Solactis has leveraged its joint‑venture roots in dairy to supply high‑quality lactulose to the European market, positioning itself as a key ingredient supplier for both pharmaceutical and functional food applications.

Sustainability & Growth Initiatives:

• Implementation of waste‑to‑energy processes in manufacturing.
• Expansion of product portfolio to include prebiotic blends.
• Enhancement of traceability through blockchain technology.

6️⃣ 6. Illovo Sugar Africa (Pty) Ltd

Headquarters: Durban, South Africa
Key Offering: Upstream lactose sourcing and ingredient supply for lactulose production

Illovo’s extensive sugar processing capabilities provide a stable raw‑material base for lactulose manufacturing, supporting regional supply chains and reducing dependency on imported lactose.

Sustainability & Growth Initiatives:

• Investment in sustainable farming practices to reduce water usage.
• Partnerships with local dairy cooperatives to secure raw‑material supply.
• Development of low‑cost, high‑purity lactulose for emerging markets.

7️⃣ 7. Dandong Kangfu Pharmaceutical Co., Ltd.

Headquarters: Dandong, China
Key Offering: Bulk lactulose concentrate for domestic and export markets

Dandong Kangfu has rapidly expanded its production capacity, positioning itself as a leading supplier of lactulose in China and Southeast Asia.

Sustainability & Growth Initiatives:

• Implementation of ISO 14001 environmental management systems.
• Expansion of production lines to meet 70% purity demand.
• Strategic alliances with local hospitals to support clinical trials.

8️⃣ 8. Jiangsu Hi‑stone Pharmaceutical Co., Ltd.

Headquarters: Jiangsu, China
Key Offering: Bulk lactulose concentrate for the Chinese market

Jiangsu Hi‑stone has leveraged its regional distribution network to secure a strong foothold in the Chinese pharmaceutical market, focusing on high‑quality, cost‑effective products.

Sustainability & Growth Initiatives:

• Investment in energy‑efficient manufacturing technologies.
• Partnerships with national health agencies for formulary inclusion.
• Expansion of R&D into flavored, child‑friendly formulations.

9️⃣ 9. Merro Pharmaceutical

Headquarters: Wuxi, China
Key Offering: Lactulose‑based pharmaceutical products and formulations

Merro has focused on developing proprietary lactulose formulations tailored to specific therapeutic indications, including pediatric constipation and hepatic encephalopathy.

Sustainability & Growth Initiatives:

• Adoption of lean manufacturing practices to reduce waste.
• Collaboration with academic research centers for preclinical studies.
• Expansion into emerging markets through joint ventures.

🔟 10. Bayer AG

Headquarters: Leverkusen, Germany
Key Offering: Pharmaceutical formulations and clinical support for lactulose therapy

Bayer’s extensive R&D portfolio and global distribution network enable it to offer lactulose products that meet the highest regulatory standards, supporting prescriber confidence worldwide.

Sustainability & Growth Initiatives:

• Investment in green chemistry for lactulose synthesis.
• Partnerships with hospitals to support patient adherence programs.
• Commitment to 100% renewable energy in manufacturing facilities by 2035.

---

Download FREE Sample Report: Lactulose Concentrate Syrup Market – View in Detailed Research Report

Get Full Report: Lactulose Concentrate Syrup Market – View in Detailed Research Report

---

Outlook

The lactulose concentrate syrup market is poised for steady growth through 2034, driven by an expanding geriatric population and rising prevalence of liver diseases. The shift towards high‑purity 70% formulations and the integration of lactulose into functional food and prebiotic segments are expected to create new revenue streams. Continued investment in digital health and patient‑adherence solutions will further strengthen market dynamics.

Future Trends

Key trends shaping the market include the expansion of over‑the‑counter availability in developed regions, the adoption of flavored and child‑friendly formulations to improve compliance, and the integration of lactulose into prebiotic and gut‑health products. Manufacturers are also focusing on sustainability, with initiatives such as renewable energy adoption, waste‑to‑energy processes, and circular packaging solutions becoming critical differentiators in a highly competitive landscape.